Income Taxes (Details Narrative) - USD ($) |
12 Months Ended | ||
---|---|---|---|
Dec. 22, 2017 |
Dec. 31, 2017 |
Dec. 31, 2016 |
|
Income Tax Disclosure [Line Items] | |||
Increase in income tax benefit | $ 414,000 | ||
Decrease in net deferred tax liabilities | 414,000 | ||
Deferred tax assets | $ 0 | $ 2,940,000 | |
Operating loss carryforwards expiration period | beginning in 2031 through 2036 | ||
Operating loss carryovers begin expire term | 5 years | ||
Change in Valuation Allowance | $ (3,188,148) | 1,858,543 | |
Outstanding liability | |||
Tax Cuts and Jobs Act [Member] | |||
Income Tax Disclosure [Line Items] | |||
U.S. corporate income tax rate | 35.00% | ||
Reduction in U.S. corporate income tax rate | 21.00% | ||
U.S. Federal and State [Member] | |||
Income Tax Disclosure [Line Items] | |||
Operating loss carryovers | 38,590,000 | 32,893,000 | |
Foreign [Member] | South Africa [Member] | |||
Income Tax Disclosure [Line Items] | |||
Foreign operating loss carryovers net | $ 2,360,000 | $ 1,352,000 |
X | ||||||||||
- Definition IncomeTax Disclosure Line Items. No definition available.
|
X | ||||||||||
- Definition Expiration period of each operating loss carryforward included in operating loss carryforward No definition available.
|
X | ||||||||||
- Definition Operating loss carryovers begin expire term. No definition available.
|
X | ||||||||||
- Definition Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible foreign operating loss carryforwards. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to deductions. Including, but not limited to, extraterritorial income exclusion deduction, qualified production activity deduction, dividend deduction, deduction for dividend paid to employee stock ownership plan, Medicare prescription drug benefit subsidy deduction, and other deductions. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition Amount of fresh-start adjustment to deferred income tax liabilities. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition The increase (decrease) during the reporting period in the amounts payable to taxing authorities for taxes that are based on the reporting entity's earnings, net of amounts receivable from taxing authorities for refunds of overpayments or recoveries of income taxes, and in deferred and other tax liabilities and assets. No definition available.
|
X | ||||||||||
- Definition Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition Amount of undistributed earnings of domestic subsidiaries or domestic joint ventures intended to be permanent. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|